HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ida Franiak-Pietryga Selected Research

maltotriose

1/2020Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
1/2014Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
6/2013The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ida Franiak-Pietryga Research Topics

Disease

8Neoplasms (Cancer)
01/2022 - 01/2014
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 01/2012
1Brain Neoplasms (Brain Tumor)
07/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022
1Squamous Cell Carcinoma of Head and Neck
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020
1Disease Progression
01/2013

Drug/Important Bio-Agent (IBA)

6Dendrimers (Dendrons)IBA
07/2022 - 06/2013
4poly(propyleneimine)IBA
07/2022 - 06/2013
3Pharmaceutical PreparationsIBA
01/2022 - 01/2014
3maltotrioseIBA
01/2020 - 06/2013
2fludarabineIBA
01/2020 - 01/2012
2Rituximab (Mabthera)FDA Link
10/2012 - 09/2012
2CladribineFDA LinkGeneric
09/2012 - 01/2012
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1AntibodiesIBA
01/2022
1auristatinIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1monomethyl auristatin EIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1SilverIBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2020
1TNF-Related Apoptosis-Inducing LigandIBA
01/2017
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1SolutionsIBA
01/2014
1MaltoseIBA
01/2014
1Complementary DNA (cDNA)IBA
01/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2012

Therapy/Procedure

5Therapeutics
01/2020 - 01/2013
2Radiotherapy
01/2022 - 01/2020
2Immunotherapy
01/2022 - 01/2022